Auto‐antibody profile and clinical presentation of Vietnamese with systemic sclerosis

2020 ◽  
Author(s):  
Hien Thi Thu Do ◽  
Thao Nhi Thi Nguyen ◽  
Doanh Huu Le ◽  
Takuro Kanekura
Keyword(s):  
Systemic Sclerosis ◽  
Clinical Presentation ◽  
Antibody Profile ◽  
Auto Antibody

Uncommon clinical presentation of a lymphocytic lymphoma of intermediate differentiation in a patient with systemic sclerosis

1994 ◽  
Vol 86 (3) ◽  
pp. 657-658 ◽  
Author(s):  
L. Baldini ◽  
A. Guffanti ◽  
A. Ferrari ◽  
D. Castagnone ◽  
B. Mascagni ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Clinical Presentation

P137 The importance of re-evaluating the HLA antibody profile and auto-antibody status when the flow cytometry crossmatch result is not as expected

2016 ◽  
Vol 77 ◽  
pp. 138
Author(s):  
Blanca Ponce-Ngo ◽  
Jiali Shen ◽  
Marzanna Krolik ◽  
Scott Hodgson ◽  
Angelo N. Arnold
Keyword(s):  
Flow Cytometry ◽  
Antibody Profile ◽  
Auto Antibody ◽  
Hla Antibody

scholarly journals Erratum to “Clinical Presentation and Long-Term Outcomes of Systemic Sclerosis Portuguese Patients from a Single Centre Cohort: A EUSTAR Registration Initiative”

2018 ◽  
Vol 31 (9) ◽  
pp. 520
Author(s):  
Carolina Vidal ◽  
Carina Ruano ◽  
Vera Bernardino ◽  
Pedro Lavado Carreira ◽  
Ana Lladó ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Clinical Presentation ◽  
Long Term Outcomes ◽  
Single Centre ◽  
Espírito Santo ◽  
Espirito Santo ◽  
De Medicina

Article published with errors: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/10658On page 312, where the authors’ line reads as:Carolina VIDAL1, Carina RUANO2, Vera BERNARDINO3, Pedro LAVADO CARREIRA3, Ana LLADÓ3, Maria Céu SANTOS4, Heidi GRUNER3, António PANARRA3, Nuno RISO3, Maria Francisca MORAES-FONTESAC,1It should read:Carolina VIDAL1,2, Carina RUANO3, Vera BERNARDINO1, Pedro LAVADO CARREIRA1, Ana LLADÓ1, Maria Céu SANTOS4, Heidi GRUNER1, António PANARRA1, Nuno RISO1, Maria Francisca MORAES-FONTESAC,1 On the same page, where the authors’ affiliation on the footer reads as:Serviço de Medicina Interna. Hospital do Divino Espírito Santo de Ponta Delgada. São Miguel. Portugal.Serviço de Radiologia. Hospital de Santa Marta. Centro Hospitalar de Lisboa Central. Lisboa. Portugal.Unidade de Doenças Auto-Imunes/Serviço Medicina 7.2. Hospital de Curry Cabral. Centro Hospitalar de Lisboa Central. Lisboa. Portugal.Laboratório de Imunologia. Centro Hospitalar de Lisboa Central. Lisboa. Portugal. It should read:Unidade de Doenças Auto-Imunes/Serviço Medicina 7.2. Hospital de Curry Cabral. Centro Hospitalar de Lisboa Central. Lisboa. Portugal.Serviço de Medicina Interna. Hospital do Divino Espírito Santo de Ponta Delgada. São Miguel. Portugal.Serviço de Radiologia. Hospital de Santa Marta. Centro Hospitalar de Lisboa Central. Lisboa. Portugal.Laboratório de Imunologia. Centro Hospitalar de Lisboa Central. Lisboa. Portugal.  

AB0643 The Ψ-Reuma Project: Role of Early and Recent Life Events on Systemic Sclerosis (SSC) Clinical Presentation and Course

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 1018.1-1018
Author(s):  
F. Rotella ◽  
F. Pietrini ◽  
L. Lelli ◽  
S. Guiducci ◽  
S. Bellando-Randone ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Life Events ◽  
Clinical Presentation

scholarly journals Juvenile Systemic Sclerosis- A Case Report

2018 ◽  
Vol 29 (2) ◽  
pp. 70-72
Author(s):  
ASMM Rahman ◽  
MB Uddin
Keyword(s):  
Case Report ◽  
Systemic Sclerosis ◽  
Rare Disease ◽  
Clinical Presentation ◽  
Organ Involvement ◽  
Published Data ◽  
Multisystem Disorder ◽  
Adult Disease ◽  
Adult Form ◽  
Juvenile Systemic Sclerosis

Juvenile systemic sclerosis (JSS) is a multisystem disorder as well as rare disease of childhood, and the amount of published data is limited. It appears that its clinical presentation differs from adult disease and the limited form affects only very few children. The organ involvement pattern differs also from the adult form. Prognosis seems to be better with a 5-yr survival of 95% of the JSS patients. Though the incidence is very rare but we describe a 10-yr-old boy who presented with typical features of JSS.TAJ 2016; 29(2): 70-72

Differences in clinical presentation and incidence of cardiopulmonary involvement in late-onset versus early-onset systemic sclerosis: inception cohort study

2018 ◽  
Vol 21 (5) ◽  
pp. 1082-1092 ◽  
Author(s):  
Suparaporn Wangkaew ◽  
Phiriya Phiriyakrit ◽  
Vittawin Sawangduan ◽  
Narawudt Prasertwittayakij ◽  
Juntima Euathrongchit
Keyword(s):  
Cohort Study ◽  
Systemic Sclerosis ◽  
Early Onset ◽  
Clinical Presentation ◽  
Late Onset ◽  
Inception Cohort

scholarly journals Lipid Alterations in Systemic Sclerosis

2021 ◽  
Vol 8 ◽  
Author(s):  
Zuzanna Gogulska ◽  
Zaneta Smolenska ◽  
Jacek Turyn ◽  
Adriana Mika ◽  
Zbigniew Zdrojewski
Keyword(s):  
Fatty Acids ◽  
Systemic Sclerosis ◽  
Metabolic Pathways ◽  
Poor Prognosis ◽  
Clinical Presentation ◽  
Current Knowledge ◽  
Cellular Membrane ◽  
Serum Lipoproteins ◽  
Personalized Approach ◽  
Membrane Components

Background: Systemic sclerosis (SSc) is an autoimmune disease with an elusive etiology and poor prognosis. Due to its diverse clinical presentation, a personalized approach is obligatory and needs to be based on a comprehensive biomarker panel. Therefore, particular metabolomic studies are necessary. Lipidomics addressed these issues and found disturbances in several crucial metabolic pathways.Aim of Review: The review aims to briefly summarize current knowledge related to lipid alterations in systemic sclerosis, highlight its importance, and encourage further research in this field.Key Scientific Concepts of Review: In this review, we summarized the studies on the lipidomic pattern, fatty acids, lipoproteins, cholesterol, eicosanoids, prostaglandins, leukotrienes, lysophospholipids, and sphingolipids in systemic sclerosis. Researchers demonstrated several alternate aspects of lipid metabolism. As we aimed to present our findings in a comprehensive view, we decided to divide our findings into three major groups: “serum lipoproteins,” “fatty acids and derivatives,” and “cellular membrane components,” as we do believe they play a prominent role in SSc pathology.

Clinical and Serological Hallmarks of Systemic Sclerosis Overlap Syndromes

2011 ◽  
Vol 38 (11) ◽  
pp. 2406-2409 ◽  
Author(s):  
ANGELA PAKOZDI ◽  
SVETLANA NIHTYANOVA ◽  
PIA MOINZADEH ◽  
VOON H. ONG ◽  
CAROL M. BLACK ◽  
...  
Keyword(s):  
Systemic Sclerosis ◽  
Lupus Erythematosus ◽  
Clinical Presentation ◽  
Overlap Syndrome ◽  
Disease Course ◽  
Anticentromere Antibody ◽  
Autoantibody Profile ◽  
Peptide Antibody ◽  
Clinical Records ◽  
Citrullinated Peptide

Objective.To determine the prevalence of systemic sclerosis (SSc) overlap syndrome and autoantibody profile in a large single-center cohort.Methods.SSc diagnoses, subsets, and autoantibody profiles were obtained from clinical records of patients attending the Centre for Rheumatology, Royal Free Hospital, between September 1999 and February 2007.Results.In total, 332 (20%) of 1700 patients with SSc had overlap syndrome. This comprised myositis (42.8%), rheumatoid arthritis (RA; 32%), Sjögren’s syndrome (SS; 16.8%), and systemic lupus erythematosus (SLE; 8.4%). Antinuclear antibody was positive in 96.6% of patients. Anticentromere antibody (ACA) was exclusively present in limited cutaneous SSc (lcSSc) overlap cases (22%), and more common in SSc/SS overlap (44.7%), whereas no difference was found in the prevalence of Scl-70 autoantibody between lcSSc and diffuse cutaneous SSc overlap groups. U1RNP was more frequent in SSc/SLE (44%), while Ro antibody was more likely to be found in SSc/SS (29.8%). ACA was absent and anti-Scl-70 was infrequent in SSc/myositis; polymyositis-scleroderma antibody was more frequent in this group (33.1%). About 50% of patients had raised rheumatoid factor (RF), with no difference between overlap groups irrespective of RF titer. In contrast, anticyclic citrullinated peptide antibody was more frequent in patients with RA features.Conclusion.About one-fifth of SSc cases had overlap features. There were distinct serological features that may predict specific clinical presentation and disease course.

scholarly journals Atypical clinical presentation of lichen planus bullous in a systemic sclerosis patient

2016 ◽  
Vol 5 ◽  
pp. 385-391
Author(s):  
Zofia A. Gerlicz-Kowalczuk ◽  
Jolanta D. Torzecka ◽  
Marek Kot ◽  
Bożena Dziankowska-Bartkowiak
Keyword(s):  
Systemic Sclerosis ◽  
Lichen Planus ◽  
Clinical Presentation ◽  
Atypical Clinical Presentation ◽  
Systemic Sclerosis Patient
Sign in / Sign up

Export Citation Format

Share Document